Alterola Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,542,457 over the previous period. Total operating expenses were $1,696,981.

Profit Margin

Alterola Biotech, Inc. (OTC:ABTI): Profit margin
2012 0 -13.25K
2013 0 -72.50K
2016 0 -22.57K
2019 0 -258.70K
2022 0 -6.47M
2023 0 -1.54M

ABTI Income Statement (2013 – 2023)

2023 2022 2020 2017 2014 2013
Revenue
Revenue
000000
Cost of revenue
000000
Gross profit
000000
Operating exp.
Research and development
46.42K2.43M0000
Selling and marketing
000000
Total operating expenses
1.69M6.47M258.45K14.73K59.13K3.65K
Operating income
-1.89M-6.47M-258.45K-14.73K-59.13K-3.65K
Other income (expenses), net
200K-1-24910.17K-2.87K-9.6K
Income before tax
-1.69M-6.47M-258.70K-22.57K-72.50K-13.25K
Income tax expense
-154.52K-107.84K2.87K0
Net income
-1.54M-6.47M-258.70K-22.57K-72.50K-13.25K
Earnings per share
Basic EPS
-0.00-0.00-0.00-0.00-0.00-0.00
Diluted EPS
-0.00-0.00-0.00-0.00-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData source